These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
372 related items for PubMed ID: 26634397
1. Tumor necrosis factor-α driven inflammation in alpha-1 antitrypsin deficiency: a new model of pathogenesis and treatment. Hurley K, Reeves EP, Carroll TP, McElvaney NG. Expert Rev Respir Med; 2016 Feb; 10(2):207-22. PubMed ID: 26634397 [Abstract] [Full Text] [Related]
2. Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals. Hurley K, Lacey N, O'Dwyer CA, Bergin DA, McElvaney OJ, O'Brien ME, McElvaney OF, Reeves EP, McElvaney NG. J Immunol; 2014 Oct 15; 193(8):3978-91. PubMed ID: 25217166 [Abstract] [Full Text] [Related]
3. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency. McCarthy C, Reeves EP, McElvaney NG. Ann Am Thorac Soc; 2016 Aug 15; 13 Suppl 4():S297-304. PubMed ID: 27564664 [Abstract] [Full Text] [Related]
4. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence. Rahaghi FF, Miravitlles M. Respir Res; 2017 May 30; 18(1):105. PubMed ID: 28558837 [Abstract] [Full Text] [Related]
5. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling. O'Dwyer CA, O'Brien ME, Wormald MR, White MM, Banville N, Hurley K, McCarthy C, McElvaney NG, Reeves EP. J Immunol; 2015 Oct 15; 195(8):3628-41. PubMed ID: 26371243 [Abstract] [Full Text] [Related]
6. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency. Lascano JE, Campos MA. Postgrad Med; 2017 Nov 15; 129(8):889-895. PubMed ID: 28929906 [Abstract] [Full Text] [Related]
7. Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies. Turner AM. BioDrugs; 2013 Dec 15; 27(6):547-58. PubMed ID: 23771682 [Abstract] [Full Text] [Related]
8. Pathophysiology of Alpha-1 Antitrypsin Lung Disease. Kalfopoulos M, Wetmore K, ElMallah MK. Methods Mol Biol; 2017 Dec 15; 1639():9-19. PubMed ID: 28752442 [Abstract] [Full Text] [Related]
9. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review. Edgar RG, Patel M, Bayliss S, Crossley D, Sapey E, Turner AM. Int J Chron Obstruct Pulmon Dis; 2017 Dec 15; 12():1295-1308. PubMed ID: 28496314 [Abstract] [Full Text] [Related]
10. Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency. Jarosch I, Hitzl W, Koczulla AR, Wencker M, Welte T, Gloeckl R, Janciauskiene S, Kenn K. Respir Med; 2017 Sep 15; 130():98-101. PubMed ID: 29206641 [Abstract] [Full Text] [Related]
11. Alpha-1 Antitrypsin Therapy Modifies Neutrophil Adhesion in Patients with Obstructive Lung Disease. McEnery T, White MM, Gogoi D, Coleman O, Bergin D, Jundi B, Flannery R, Alsaif FAT, Landers SA, Casey M, Dunlea D, Meleady P, McElvaney NG, Reeves EP. Am J Respir Cell Mol Biol; 2022 Jul 15; 67(1):76-88. PubMed ID: 35507773 [Abstract] [Full Text] [Related]
12. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update. Casas F, Blanco I, Martínez MT, Bustamante A, Miravitlles M, Cadenas S, Hernández JM, Lázaro L, Rodríguez E, Rodríguez-Frías F, Torres M, Lara B. Arch Bronconeumol; 2015 Apr 15; 51(4):185-92. PubMed ID: 25027067 [Abstract] [Full Text] [Related]
13. Alpha 1 Antitrypsin-Deficient Macrophages Have Impaired Efferocytosis of Apoptotic Neutrophils. Lee J, Lu Y, Oshins R, West J, Moneypenny CG, Han K, Brantly ML. Front Immunol; 2020 Apr 15; 11():574410. PubMed ID: 33329539 [Abstract] [Full Text] [Related]
15. Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency. Belchamber KBR, Walker EM, Stockley RA, Sapey E. Int J Chron Obstruct Pulmon Dis; 2020 Aug 10; 15():3183-3192. PubMed ID: 33311976 [Abstract] [Full Text] [Related]
16. α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency. Bazzan E, Tinè M, Biondini D, Benetti R, Baraldo S, Turato G, Fagiuoli S, Sonzogni A, Rigobello C, Rea F, Calabrese F, Foschino-Barbaro MP, Miranda E, Lomas DA, Saetta M, Cosio MG. Chest; 2018 Sep 10; 154(3):607-616. PubMed ID: 29763589 [Abstract] [Full Text] [Related]
17. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm. Baraldo S, Turato G, Lunardi F, Bazzan E, Schiavon M, Ferrarotti I, Molena B, Cazzuffi R, Damin M, Balestro E, Luisetti M, Rea F, Calabrese F, Cosio MG, Saetta M. Am J Respir Crit Care Med; 2015 Feb 15; 191(4):402-9. PubMed ID: 25412116 [Abstract] [Full Text] [Related]
18. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency. O'Brien ME, Fee L, Browne N, Carroll TP, Meleady P, Henry M, McQuillan K, Murphy MP, Logan M, McCarthy C, McElvaney OJ, Reeves EP, McElvaney NG. Thorax; 2020 Apr 15; 75(4):321-330. PubMed ID: 31959730 [Abstract] [Full Text] [Related]
20. Novel variants of SERPIN1A gene: Interplay between alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease. Bashir A, Shah NN, Hazari YM, Habib M, Bashir S, Hilal N, Banday M, Asrafuzzaman S, Fazili KM. Respir Med; 2016 Aug 15; 117():139-49. PubMed ID: 27492524 [Abstract] [Full Text] [Related] Page: [Next] [New Search]